Coronary Heart Disease
Studies by I.T. Meredith and co-authors describe new findings in coronary heart disease
Published in Cardiovascular Week, February 1st, 2010
In this recent report, researchers in Clayton, Australia conducted a study "To evaluate the 5-year clinical outcomes of patients treated with the Endeavor zotarolimus-eluting stent (ZES) in the ENDEAVOR I first-in-human study. ENDEAVOR I was a prospective, nonrandomized, multicenter study of the Endeavor ZES in 100 consecutive patients with symptomatic coronary artery disease (CAD) due to de novo, stenotic lesions in native coronary arteries."
"Patients with single or multivessel CAD were eligible to participate, but only one lesion per patient was treated. The lesion had to have >= 50% stenosis, be <= 15 mm in length, and located in a vessel with a reference...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2010-02-01)
More Articles from Cardiovascular Week
- Columbia University Medical Center
Columbia researchers show link between lung disease and heart function - Edelman Public Relations
New data show cardiac respiratory stress test can quickly detect significant coronary artery disease - JAMA and Archives Journals
Link examined between omega-3 fatty acid levels and biological aging marker in patients with CHD - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
New way to generate abundant functional blood vessel cells from human stem cells discovered - University of Rochester Medical Center
URMC study links vitamin D, race and cardiac deaths - Abdominal Aortic Aneurysm
Data on abdominal aortic aneurysm detailed by M.A.M. Peirano and co-authors - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
